• AstraZeneca EPS for the quarter ending September 30, 2024 was $0.46, a 3.41% increase year-over-year.
• AstraZeneca 2023 annual EPS was $1.91, a 80.57% increase from 2022.
• AstraZeneca 2022 annual EPS was $1.06, a 2537.5% increase from 2021.
• AstraZeneca 2021 annual EPS was $0.04, a 96.72% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.